Annual retention fee payment notification for the Financial year ending 31 March 2020

Your attention is drawn to the provisions of the Medicines and Related Substances Act, 1965 (Act 101 of 1965) as amended, making provision for the payment of retention fees to the Regulatory Authority in respect of medicines, medical devices and IVDs registered and site licences issued. These retention fees are payable no later than 30 June 2023, failing which the registration or licence may be cancelled.

Payment of Retention Fees for the Financial Year Ending 31 March 2020 in Respect of Medicines Registered Up and Until 31 December 2019 and/or Manufacture or Wholesale Licences